BNET Industries
- Private
- US
Co-Founder and President of Amphioxus Cell Technol
James H KellyContact Information
11222 Richmond Ave Ste 180
Houston, Texas 77082-2646
1 281 679 7900
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Decision Makers
| Name (plus bio) | Position |
|---|---|
| James H Kelly | Co-Founder and President of Amphioxus Cell Technol |
| Ivo Piest | Senior Director |
| Ellen De Waal | Manager |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Lucio A. Noto | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Stem Cell Innovations, Inc | Co-Founder and President of Amphioxus Cell Technol | Current |
| Organization | Position | Status |
|---|---|---|
| Stem Cell Innovations, Inc | Senior Director | Current |
| Organization | Position | Status |
|---|---|---|
| Stem Cell Innovations, Inc | Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Midstream Partners LLC | Managing Partner | Current |
| Shinsei Capital (USA), Ltd. | Director, Conferences | Current |
| Temasek Holdings Pte Ltd. | International Advisory Council | Current |
| Shinsei Bank, Limited | Board of Directors | Current |
| Stem Cell Innovations, Inc | Board of Directors | Current |
| Exxon Mobil Corporation | Chairman & CEO | Former |
| Exxon Mobil Corporation | Vice Chairman | Former |
| International Business Machines Corporation | Board of Directors | Former |
Executive News
-
Meet the Men Who Are Being Handed the Keys
-
Chrysler's Nardelli tells judge Fiat sale is best deal for all
-
Fiat sets its three picks for Fiat-Chrysler board
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes


